Cargando…
Tocotrienols for normalisation of hepatic echogenic response in nonalcoholic fatty liver: a randomised placebo-controlled clinical trial
BACKGROUND: Nonalcoholic fatty liver disease (NAFLD) is one of the commonest liver disorders. Obesity, insulin resistance, lipid peroxidation and oxidative stress have been identified amongst the possible hits leading to the onset and progression of this disease. Nutritional evaluation of NAFLD pati...
Autores principales: | Magosso, Enrico, Ansari, Mukhtar Alam, Gopalan, Yogheswaran, Shuaib, Ibrahim Lutfi, Wong, Jia-Woei, Khan, Nurzalina Abdul Karim, Abu Bakar, Mohamed Rizal, Ng, Bee-Hong, Yuen, Kah-Hay |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3877967/ https://www.ncbi.nlm.nih.gov/pubmed/24373555 http://dx.doi.org/10.1186/1475-2891-12-166 |
Ejemplares similares
-
Formulation and In Vivo Evaluation of a Solid Self-Emulsifying Drug Delivery System Using Oily Liquid Tocotrienols as Model Active Substance
por: Lee, You Zhuan, et al.
Publicado: (2021) -
Effect of tocotrienol on the primary progression of nonalcoholic steatohepatitis in a mouse model
por: Noichi, Jun, et al.
Publicado: (2022) -
Tocotrienol in the Management of Nonalcoholic Fatty Liver Disease: A Systematic Review
por: Chin, Kok-Yong, et al.
Publicado: (2023) -
Magnetic stimulation for stress urinary incontinence: study protocol for a randomized controlled trial
por: Lim, Renly, et al.
Publicado: (2015) -
Echogenicity and echocardiographic guidance
por: Balcı, Kevser Gülcihan, et al.
Publicado: (2019)